KRX/137310 (KRX/137310)

Korea Stock Exchange: KRX/137310 · KRW

₩6,260

-79.88 (-1.3%)· Recorded snapshot

Market cap	748.8B
Revenue (ttm)	738.8B
Net income (ttm)	-729.5B
EPS (ttm)	-₩6,098
Shares out	119.6M
Dividend	₩200 (3.19%)
Volume	145,433
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 738.8B
Net income (ttm): -729.5B
EPS (ttm): -₩6,098
Market cap: 748.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-26.9

P25 n/aP50 n/aP75 n/a

ROIC-3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All KRX/137310 indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

KRW

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Earnings date	2026-11-14
Employees	616
Enterprise value	KRW 594.4B
Exchange	Korea Stock Exchange
Financial currency	KRW
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Medical Devices
Is primary listing	Yes
ISIN number	KR7137310009
Last earnings date	2026-05-15
Last refreshed	2026-10-28
Market cap	KRW 748.8B
Next earnings date	2026-11-14
Price	KRW 6,260.00
Price currency	KRW
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	krx/137310
Website	https://www.sdbiosensor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-97.41%
EV/EBITDA	12.61x
EV/FCF	53.41x
EV/Sales	0.8x
FCF / EV yield	1.87%
FCF yield	1.49%
Industry forward P/E	12.72x
P/(OCF - SBC) ratio	16.57x
P/B ratio	0.31x
P/FCF ratio	67.29x
P/OCF ratio	13.2x
P/S ratio	1.01x
Price / tangible book value	0.69x
Price/EBITDA ratio	12.5x
Sector forward P/E	24.95x
Sector P/E	49.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-8.91%
EBITDA margin	8.11%
FCF margin	1.51%
Gross margin	46.16%
Operating margin	-8.91%
Pretax margin	-107.57%
Profit margin	-98.75%
Profit per employee	KRW -1.2B
Profitable quarters	2
Revenue per employee	KRW 1.2B
ROA	-1.21%
ROA (5Y)	10.92%
ROCE	-2.38%
ROE	-26.9%
ROE (5Y)	13.76%
ROIC	-2.97%
ROIC (5Y)	67.02%
SBC / revenue	1.56%
Tax / revenue	-8.61%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-94.05%
EPS growth (QoQ)	-27.82%
EPS growth years	0
FCF growth	-96.77%
FCF growth 3Y	-63.85%
FCF growth 5Y	-58.29%
Gross profit growth	0.54%
Gross profit growth (Q)	16.22%
Gross profit growth 3Y	3.15%
Gross profit growth 5Y	-28.43%
Net income growth (Q)	-94.02%
Net income growth (QoQ)	-27.49%
Net income growth years	0
OCF growth	-86.35%
OCF growth (Q)	-99.51%
OCF growth 3Y	-48.1%
OCF growth 5Y	-44.25%
Revenue growth	5.15%
Revenue growth (Q)	12%
Revenue growth (QoQ)	-3.64%
Revenue growth 3Y	-12.26%
Revenue growth 5Y	-26.42%
Revenue growth quarters	3
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -45.6B
Depreciation and amortization	KRW 125.7B
EBIT	KRW -65.8B
EBITDA	KRW 59.9B
EPS	KRW -6,098.16
FCF per share	KRW 93.04
Financing cash flow	KRW -443.3B
Free cash flow	KRW 11.1B
Free cash flow minus SBC	KRW -416.8M
Gross profit	KRW 341B
Income taxes	KRW -63.6B
Investing cash flow	KRW 334.5B
Net borrowing	KRW -417.6B
Net cash flow	KRW -43.4B
Net income	KRW -729.5B
Operating cash flow minus SBC	KRW 45.2B
Operating income	KRW -65.8B
Revenue	KRW 738.8B
Stock-based compensation	KRW 11.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.47
Book value per share	KRW 20,062.20
Debt / EBITDA	4.82
Debt / equity	0.12
Debt / FCF	25.98
Goodwill	KRW 843.1B
Interest coverage	-0.73
Long-term assets	KRW 2T
Long-term liabilities	KRW 355.6B
Net cash (debt)	KRW 160.4B
Net cash / market cap	21.42%
Net cash growth	-1.93%
Net debt / EBITDA	-2.68
Net debt / equity	-0.07
Net debt / FCF	-14.41
Piotroski F-Score	4
Property, plant and equipment	KRW 446.5B
Shareholders' equity	KRW 2.4T
Tangible book value	KRW 1.1T
Tangible book value per share	KRW 9,085.09
Total assets	KRW 2.9T
Total cash	KRW 449.5B
Total debt	KRW 289.1B
Total liabilities	KRW 495.9B
WACC	12.73%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.22
Current assets	KRW 913.3B
Current liabilities	KRW 140.3B
Current ratio	6.51
Inventory turnover	1.64
Net working capital	KRW 335.1B
Quick ratio	4.21
Working capital	KRW 773B
Working capital turnover	0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.09%
Dividend growth	0%
Dividend growth (3Y)	-41.32%
Dividend growth years	0
Dividend payment date	2026-04-17
Dividend payment years	1
Dividend payout frequency	Annual
Dividend per share	KRW 200.00
Dividend yield	3.2%
Ex-dividend date	2026-03-30
FCF payout ratio	214.97%
Last dividend	KRW 200.00
Shareholder yield	4.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	KRW 6,974.27
1D price change	-1.26%
1M price change	3.13%
1M total return	3.13%
1W price change	-6.29%
1W total return	-6.29%
1Y price change	-37.46%
1Y return CAGR	-35.9%
1Y total return	-35.89%
20-day SMA	KRW 6,543.00
200-day SMA	KRW 7,368.85
3M price change	0.16%
3M total return	0.16%
3Y price change	-35.4%
3Y return CAGR	-12.26%
3Y total return	-32.46%
50-day SMA	KRW 6,317.00
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 10,190.00
52-week high date	2025-10-28
52-week low	KRW 5,800.00
52-week low date	2026-07-23
5Y price change	-86.29%
5Y return CAGR	-30.73%
5Y total return	-84.04%
6M price change	-25.83%
6M total return	-25.83%
All-time high	KRW 81,000.00
All-time high date	2022-02-04
All-time low	KRW 5,800.00
All-time low date	2026-07-23
Average true range (ATR)	KRW 277.64
Average volume	145K
Beta (1Y)	0.41
Beta (2Y)	0.19
Beta (5Y)	0.7
Change from 52-week high	-38.57%
Change from 52-week low	7.93%
Change from all-time high	-92.27%
Change from all-time low	7.93%
Change from open	-1.42%
Day's gap	0.16%
Dollar volume	KRW 910.4M
High price	KRW 6,450.00
Low price	KRW 6,200.00
Monthly RSI	30.46
Open price	KRW 6,350.00
Position in 52-week range	24%
Previous close	KRW 6,340.00
Price vs 150-day SMA	-10.24%
Price vs 20-day SMA	-4.33%
Price vs 200-day SMA	-15.05%
Price vs 50-day SMA	-0.9%
Relative volume	1.01
RSI	43.84
Sharpe ratio	-0.8
Sharpe ratio (3Y)	-0.34
Sharpe ratio (5Y)	-0.59
Sortino ratio	-0.99
Sortino ratio (3Y)	-0.39
Sortino ratio (5Y)	-0.8
Volume	145.4K
Weekly RSI	42.13
YTD price change	-29.66%
YTD total return	-27.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32M
Shares change (QoQ)	0.47%
Shares change (YoY)	-1.09%
Shares held by insiders	32.52%
Shares held by institutions	1.79%
Shares outstanding	119.6M

Deeper analysis on KRX/137310

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this KRX/137310 report

Is a complete KRX/137310 research report available?

No complete published report is available for krx/137310 (KRX/137310) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KRX/137310 (KRX/137310)

Price

Financial snapshot

Fair-value bridge

Latest news · KRX/137310

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRX/137310 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KRX/137310

Frequently asked questions